期刊
CURRENT PSYCHIATRY REPORTS
卷 14, 期 6, 页码 667-675出版社
SPRINGER
DOI: 10.1007/s11920-012-0319-2
关键词
Bipolar disorder; BD; Staging; Clinical staging model; Neuroprogression; Cellular resilience; Neuroplasticity; Biomarkers; Allostatic load; Treatment; Remission; Psychiatry
类别
资金
- NARSAD
- Stanley Medical Research Institute
- CNPq (National Council for Scientific and Technological Development)
- CAPES
- Eli Lilly and Company
- Lundbeck
- AstraZeneca
- Servier
- Janssen
The apparently progressive nature of a considerable proportion of cases of bipolar disorder (BD) has been acknowledged in recently proposed clinical staging models. This has been part of an attempt to facilitate and refine diagnosis, treatment selection, and establish a prognosis. The study of the progressive nature of some cases of BD has given raise to the hypothesis of neuroprogression, which postulates that different stages of BD are associated with distinct neurobiological underpinnings. Given that BD may be intimately associated with chronic stress response and coping mechanisms over the course of illness, we propose that cellular resilience mechanisms may play a key role in the neuroprogression in BD. In the present study, we review neuroanatomical evidence of the progression that occurs in many cases of BD, as well as cellular resilience mechanisms and peripheral biomarkers associated with distinct stages of this disorder. In summary, cellular resilience mechanisms seem to be less efficient at later stages of BD, especially mitochondrial and endoplasmic reticulum-related responses to stress. These insights may help in developing staging models of BD, with a special emphasis on the search for biomarkers associated with illness progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据